Anemia Podcasts This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis
Anaemia is very common among patients with moderate or severe chronic kidney disease; and several treatments are available including iron supplementation, blood transfusions and synthetic derivatives of erythropoietin. In a Cochrane Review published in December 2014, Suetonia Palmer from Christchurch in New Zealand together with her colleagues, brought together the studies that have tested a range of erythropoietin drugs and she tells us what they found in this Evidence Pod. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - July 8, 2015 Category: Journals (General) Authors: Cochrane Source Type: podcasts

Intermittent preventive antimalarial treatment for children with anaemia
In some areas of health care, we use a treatment for one condition to try to help people with something else. One example is the use of anti-malaria treatments for children with anaemia and the evidence for this was examined in a new Cochrane Review in January 2015. Anke Rohwer from the Centre for Evidence-based Health Care at Stellenbosch University in South Africa describes the rationale and the findings in this Evidence Pod. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - April 20, 2015 Category: Journals (General) Authors: Cochrane Source Type: podcasts

ASH 2014 Coverage: Dealing with Anemia and Fatigue with MPNs
Anemia remains one of the greatest unmet needs in the treatment of myelofibrosis. At the 2014 American Society of Hematology Meeting, Dr. Ruben Mesa joined Patient Power to discuss MPN-related anemia ... Author: patientpower Added: 12/17/2014 (Source: Oncology Tube)
Source: Oncology Tube - December 17, 2014 Category: Cancer & Oncology Source Type: podcasts

Lawrence Tim Goodnough, MD - Anemia in Chronic Kidney Disease: Practical Strategies to Optimize the Use of Iron Therapy
Anemia in Chronic Kidney Disease: Practical Strategies to Optimize the Use of Iron Therapy (Source: PeerView CME/CE Audio Podcast - Hematology)
Source: PeerView CME/CE Audio Podcast - Hematology - August 11, 2014 Category: Hematology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

Considerations in Predialysis Anemia Treatment
Are clinicians so focused on good outcomes that they overlook quality of life in some predialysis patients? Dr. Jeffrey Berns reviews a new study on the topic. (Source: Medscape Nephrology Podcast)
Source: Medscape Nephrology Podcast - July 31, 2014 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts

What Are Anemia, Cytopenia and Thrombocytopenia?
Dr. Jorge Cortes of MD Anderson Cancer Center, breaks downs the meaning behind several side effects, including anemia, cytopenia and thrombocytopenia, experienced by many MPN patients. He illustrates ... Author: patientpower Added: 06/29/2014 (Source: Oncology Tube)
Source: Oncology Tube - June 30, 2014 Category: Cancer & Oncology Source Type: podcasts

Myeloproliferative Neoplasms (MPNs): What Are the Demographics?
Dr. Ruben Mesa explores the different faces of MPNs and divides the diseases into various stages. He discusses specific side effects, such as an enlarged spleen, fatigue and anemia, that plague many M... Author: patientpower Added: 03/12/2014 (Source: Oncology Tube)
Source: Oncology Tube - March 13, 2014 Category: Cancer & Oncology Source Type: podcasts

End Cancer: The Schmidt family story
In spring 2013, Will Schmidt underwent a colonoscopy after blood work showed he was extremely anemic. Once the anesthesia had worn off, the father of three young children learned that he had a lar... Author: mdanderson Added: 10/01/2013 (Source: Oncology Tube)
Source: Oncology Tube - October 1, 2013 Category: Cancer & Oncology Source Type: podcasts

Does Anemia or Low Platelets Preclude the Use of an Approved JAK2 Inhibitor?
Anemia, low red cell count, and low platelets can be worrisome for patients with myelofibrosis and their doctors. It can happen when a new JAK2 inhibitor medicine is used. But in the opinion of a lead... Author: patientpower Added: 04/26/2013 (Source: Oncology Tube)
Source: Oncology Tube - April 26, 2013 Category: Cancer & Oncology Source Type: podcasts

Huge Shift From EPO to Iron: Worrisome
Jeffrey Berns discusses the DOPPS results on anemia management: Erythropoietin use is way down and iron administration is way up; this is probably not a good thing. (Source: Medscape Nephrology Podcast)
Source: Medscape Nephrology Podcast - February 6, 2013 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts

Understanding Why MDS Patients Have Anemia
Dr. Janis Abkowitz, hematology-oncology specialist from the Seattle Cancer Care Alliance, explains research results reported at The 2012 American Society of Hematology Meeting that unlock the reason f... Author: patientpower Added: 01/15/2013 (Source: Oncology Tube)
Source: Oncology Tube - January 16, 2013 Category: Cancer & Oncology Source Type: podcasts

JAMA: 2011-10-12, Vol. 306, No. 14, Author in the Room™ Audio Interview
Interview with Daniel Leffler, MD, MS, author of Celiac Disease Diagnosis and Management: A 46-Year-Old Woman With Anemia. Summary points: 1. Celiac disease can present at any age with a wide variety of signs and symptoms and delay in diagnosis is common. 2. Testing for celiac disease with IgA tissue transglutaminase is accurate and cost-effective. 3. The only treatment for celiac disease is the gluten-free diet, but this is very burdensome and requires ongoing education and support. (Source: JAMA Author in the Room)
Source: JAMA Author in the Room - December 22, 2011 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts

JAMA: 2011-10-12, Vol. 306, No. 14, Author in the Room ™ Audio Interview
Interview with Daniel Leffler, MD, MS, author of Celiac Disease Diagnosis and Management: A 46-Year-Old Woman With Anemia. Summary points: 1. Celiac disease can present at any age with a wide variety of signs and symptoms and delay in diagnosis is common. 2. Testing for celiac disease with IgA tissue transglutaminase is accurate and cost-effective. 3. The only treatment for celiac disease is the gluten-free diet, but this is very burdensome and requires ongoing education and support. (Source: JAMA Author in the Room)
Source: JAMA Author in the Room - December 22, 2011 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts

Hereditary Spherocytosis: A Patient's Journey
Ezra, age 6, suffers from a rare hereditary disease, spherocytosis, which leads to severe anemia. When Ezra was born, his parents were told he had less than two weeks to live, and blood transfusions ... Author: ash Added: 05/10/2011 (Source: Oncology Tube)
Source: Oncology Tube - May 10, 2011 Category: Cancer & Oncology Source Type: podcasts